IFNG and pancreatitis: Administration of the cytokine combination at this dose induced pancreatitis in each group, as demonstrated by development of pancreatic damage (Fig. 4 A–E) and significant increase in plasma amylase and IFN-gamma levels (p<0.001) at Day 1 (Fig. 4G–H).